Quantcast
The MFWire
Manage Email Alerts | Sponsorships | About MFWire | Who We Are

Subscribe to MFWire.com's News Alerts [click]

Rating:Will Warren and AOC Delay This Mega Merger? Not Rated 5.0 Email Routing List Email & Route  Print Print
Wednesday, April 29, 2020

Will Warren and AOC Delay This Mega Merger?

Reported by Neil Anderson, Managing Editor

A mega merger of asset managers faces a new threat: two high-profile Democratic members of Congress.

Elizabeth Ann Warren (nee Herring)
United States Senate
Senator (D-Massachusetts)
Franklin Templeton is poised to buy Legg Mason next quarter in $6.5-billion cash and debt assumption deal, unveiled back in February shortly before the coronavirus crisis began hitting U.S. markets and the economy in a big way. Yet now Senator Elizabeth Warren (D-Massachusetts) and Representative Alexandria Ocasio-Cortez (D-New York) want to put a moratorium on a host of deals, including those with companies with upwards of $100 million in revenue, Reuters reports.

(The Legg deal appears to fit the bill, as this morning the team at the multi-boutique asset manager reported $2.9 billion in operating revenues for its fiscal 2020, which ended on March 31, 2020.)

The moratorium, which would also cover any deals that would normally be reported to the Federal Trade Commission (FTC) and many private equity and hedge fund deals, is part of a bill, the Pandemic Anti-Monopoly Act, that the two politicians say they plan to introduce. If passed by the House and Senate and signed into law by President Trump, the moratorium would last until the FTC's five members all agree "that small businesses, workers, and consumers are no longer under severe financial distress," i.e. until the end of the coronavirus crisis. 

Stay ahead of the news ... Sign up for our email alerts now
CLICK HERE

5.0
 Do You Recommend This Story?



GO TO: MFWire
Return to Top
 News Archives
2025: Q4Q3Q2Q1
2024: Q4Q3Q2Q1
2023: Q4Q3Q2Q1
2022: Q4Q3Q2Q1
2021: Q4Q3Q2Q1
2020: Q4Q3Q2Q1
2019: Q4Q3Q2Q1
2018: Q4Q3Q2Q1
2017: Q4Q3Q2Q1
2016: Q4Q3Q2Q1
2015: Q4Q3Q2Q1
2014: Q4Q3Q2Q1
2013: Q4Q3Q2Q1
2012: Q4Q3Q2Q1
2011: Q4Q3Q2Q1
2010: Q4Q3Q2Q1
2009: Q4Q3Q2Q1
2008: Q4Q3Q2Q1
2007: Q4Q3Q2Q1
2006: Q4Q3Q2Q1
2005: Q4Q3Q2Q1
2004: Q4Q3Q2Q1
2003: Q4Q3Q2Q1
2002: Q4Q3Q2Q1
 Subscribe via RSS:
Raw XML
Add to My Yahoo!
follow us in feedly


  1. ALFI Roadshow to Miami, November 12
  2. IMEA webinar - The Evolving RIA Marketplace & Increasing Use of Active ETFs, November 12
  3. MFDF webinar - Mutual Fund CCO Compensations: The MPI Annual Survey Update, November 13
  4. ALFI Roadshow to Houston, November 13
  5. 2025 Expect Miracles In Boston Gala, November 13
  6. WE Washington DC - Fall Happy Hour, November 13
  7. 2025 MMI Legal & Compliance Virtual Forum, November 13
  8. Citywire Private Assets Retreat 2025, Nov 13-14
  9. IMEA Institutional Roundtable, November 18
  10. IDC Director Segment Meeting - Directors at Small Fund Complexes, November 19
  11. Nicsa ETF Share Classes Operational Considerations, November 19
  12. MFDF webinar - ETF Dual-Class Relief Impacts on Board Oversight, November 19
  13. WE South - Offshore 360: the Macro View, November 19
  14. ICI Securities Law Developments Conference, November 20
  15. ICI Retail Alternatives and Closed-End Funds Conference, November 20
  16. MFDF webinar - Essential Strategies in Board Oversight of AI, Cybersecurity, and Emerging Technology Risks, December 1
  17. MFDF In Focus - Gartenberg Factors, December 2
  18. MFDF webinar - Digital Assets Regulatory Updates & Trends in the Industry, December 3
  19. MFDF webinar - Fixed Income Insights: Navigating Market Trends & Opportunities, December 9
  20. MFDF webinar - Navigating Co-Investment Relief for Fund Boards, December 16
  21. MFDF webinar - 2025 Fair Valuation Pricing Survey Update, December 18
  22. MFDF 2026 Directors' Institute, January 26 - 28, 2026
  23. MFDF 2026 Fund Governance & Regulatory Insights Conference, March 5 - 6, 2026




©All rights reserved to InvestmentWires, Inc. 1997-2025
14 Wall Street | 20th Floor | New York, NY 10005 | P: 212-331-8968 | F: 212-331-8998
Privacy Policy :: Terms of Use